Incretin Pharmacotherapy in Practice: What the Drugs Do, What the Trials Prove, and What the Weight Loss Is Made Of
How GLP-1 and dual-agonist drugs work, which cardiometabolic outcomes they and the other metabolic pillars have demonstrated, and how to manage lean-mass loss, gastrointestinal effects, peri-procedural risk and the weight regain that follows stopping.
Tuesday, September 29, 2026 0 views
About This Tutorial
How GLP-1 and dual-agonist drugs work, which cardiometabolic outcomes they and the other metabolic pillars have demonstrated, and how to manage lean-mass loss, gastrointestinal effects, peri-procedural risk and the weight regain that follows stopping.
Tutorials Are a Paid Feature
Interactive tutorials with quizzes and score tracking are available to Practitioner members and above. Sign in to try one tutorial for free!
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: